Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology

A Nottegar, F Tabbò, C Luchini, Matteo Brunelli, E Bria, N Veronese, Antonio Santo, Sara Cingarlini, Eliana Gilioli, C Ogliosi, A Eccher, L. Montagna, S Pedron, C Doglioni, MG Cangi, G Inghirami, M Chilosi

Research output: Contribution to journalArticle

Abstract

Pulmonary adenocarcinoma with enteric differentiation (PAED) is a rare subtype of lung adenocarcinoma recently recognized in the WHO classification. It is defined as an adenocarcinoma in which the enteric component exceeds 50% and have to show the expression of at least 1 immunohistochemical marker of enteric differentiation. Although the definition of this tumor type is very important, above all in the differential diagnosis between a primary lung tumor and a metastasis of colorectal adenocarcinoma, this cancer still lacks a distinctive immunohistochemical and molecular signature. We recruited the largest series in the literature of PAEDs according to the morphology and the positivity for intestinal markers. Then, we evaluated the immunohistochemical and molecular profile of these adenocarcinomas. In our series, CDX-2 and CK7 were the immunohistochemical markers mostly expressed by PAEDs. There was an inverse relationship between the expression of pnuemocytes markers, such as TTF-1, and intestinal markers. Molecular analysis revealed KRAS as the most frequently mutated gene (>60% of cases), with very few cases harboring abnormalities affecting EGFR, BRAF, and ALK genes. PAEDs are morphologically very heterogenous. The immunohistochemical profile based on CDX-2 and CK7 positivity of PAEDs appears very robust to support this diagnosis, and it is applicable also on small biopsies. KRAS appears as the most important mutated gene in such tumors.
Original languageEnglish
Pages (from-to)383-387
Number of pages5
JournalApplied Immunohistochemistry and Molecular Morphology
Volume26
Issue number6
DOIs
Publication statusPublished - 2018

Fingerprint

Adenocarcinoma
Immunohistochemistry
Genes
Neoplasms
Differentiation Antigens
Colorectal Neoplasms
Differential Diagnosis
Neoplasm Metastasis
Biopsy
Lung
Adenocarcinoma of lung

Cite this

Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology. / Nottegar, A; Tabbò, F; Luchini, C; Brunelli, Matteo; Bria, E; Veronese, N; Santo, Antonio; Cingarlini, Sara; Gilioli, Eliana; Ogliosi, C; Eccher, A; Montagna, L.; Pedron, S; Doglioni, C; Cangi, MG; Inghirami, G; Chilosi, M.

In: Applied Immunohistochemistry and Molecular Morphology, Vol. 26, No. 6, 2018, p. 383-387.

Research output: Contribution to journalArticle

Nottegar, A, Tabbò, F, Luchini, C, Brunelli, M, Bria, E, Veronese, N, Santo, A, Cingarlini, S, Gilioli, E, Ogliosi, C, Eccher, A, Montagna, L, Pedron, S, Doglioni, C, Cangi, MG, Inghirami, G & Chilosi, M 2018, 'Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology', Applied Immunohistochemistry and Molecular Morphology, vol. 26, no. 6, pp. 383-387. https://doi.org/10.1097/PAI.0000000000000440
Nottegar, A ; Tabbò, F ; Luchini, C ; Brunelli, Matteo ; Bria, E ; Veronese, N ; Santo, Antonio ; Cingarlini, Sara ; Gilioli, Eliana ; Ogliosi, C ; Eccher, A ; Montagna, L. ; Pedron, S ; Doglioni, C ; Cangi, MG ; Inghirami, G ; Chilosi, M. / Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology. In: Applied Immunohistochemistry and Molecular Morphology. 2018 ; Vol. 26, No. 6. pp. 383-387.
@article{8b8a98ba3cbb4e24a9c08fe2d43f9d8f,
title = "Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology",
abstract = "Pulmonary adenocarcinoma with enteric differentiation (PAED) is a rare subtype of lung adenocarcinoma recently recognized in the WHO classification. It is defined as an adenocarcinoma in which the enteric component exceeds 50{\%} and have to show the expression of at least 1 immunohistochemical marker of enteric differentiation. Although the definition of this tumor type is very important, above all in the differential diagnosis between a primary lung tumor and a metastasis of colorectal adenocarcinoma, this cancer still lacks a distinctive immunohistochemical and molecular signature. We recruited the largest series in the literature of PAEDs according to the morphology and the positivity for intestinal markers. Then, we evaluated the immunohistochemical and molecular profile of these adenocarcinomas. In our series, CDX-2 and CK7 were the immunohistochemical markers mostly expressed by PAEDs. There was an inverse relationship between the expression of pnuemocytes markers, such as TTF-1, and intestinal markers. Molecular analysis revealed KRAS as the most frequently mutated gene (>60{\%} of cases), with very few cases harboring abnormalities affecting EGFR, BRAF, and ALK genes. PAEDs are morphologically very heterogenous. The immunohistochemical profile based on CDX-2 and CK7 positivity of PAEDs appears very robust to support this diagnosis, and it is applicable also on small biopsies. KRAS appears as the most important mutated gene in such tumors.",
author = "A Nottegar and F Tabb{\`o} and C Luchini and Matteo Brunelli and E Bria and N Veronese and Antonio Santo and Sara Cingarlini and Eliana Gilioli and C Ogliosi and A Eccher and L. Montagna and S Pedron and C Doglioni and MG Cangi and G Inghirami and M Chilosi",
year = "2018",
doi = "10.1097/PAI.0000000000000440",
language = "English",
volume = "26",
pages = "383--387",
journal = "Applied Immunohistochemistry and Molecular Morphology",
issn = "1541-2016",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology

AU - Nottegar, A

AU - Tabbò, F

AU - Luchini, C

AU - Brunelli, Matteo

AU - Bria, E

AU - Veronese, N

AU - Santo, Antonio

AU - Cingarlini, Sara

AU - Gilioli, Eliana

AU - Ogliosi, C

AU - Eccher, A

AU - Montagna, L.

AU - Pedron, S

AU - Doglioni, C

AU - Cangi, MG

AU - Inghirami, G

AU - Chilosi, M

PY - 2018

Y1 - 2018

N2 - Pulmonary adenocarcinoma with enteric differentiation (PAED) is a rare subtype of lung adenocarcinoma recently recognized in the WHO classification. It is defined as an adenocarcinoma in which the enteric component exceeds 50% and have to show the expression of at least 1 immunohistochemical marker of enteric differentiation. Although the definition of this tumor type is very important, above all in the differential diagnosis between a primary lung tumor and a metastasis of colorectal adenocarcinoma, this cancer still lacks a distinctive immunohistochemical and molecular signature. We recruited the largest series in the literature of PAEDs according to the morphology and the positivity for intestinal markers. Then, we evaluated the immunohistochemical and molecular profile of these adenocarcinomas. In our series, CDX-2 and CK7 were the immunohistochemical markers mostly expressed by PAEDs. There was an inverse relationship between the expression of pnuemocytes markers, such as TTF-1, and intestinal markers. Molecular analysis revealed KRAS as the most frequently mutated gene (>60% of cases), with very few cases harboring abnormalities affecting EGFR, BRAF, and ALK genes. PAEDs are morphologically very heterogenous. The immunohistochemical profile based on CDX-2 and CK7 positivity of PAEDs appears very robust to support this diagnosis, and it is applicable also on small biopsies. KRAS appears as the most important mutated gene in such tumors.

AB - Pulmonary adenocarcinoma with enteric differentiation (PAED) is a rare subtype of lung adenocarcinoma recently recognized in the WHO classification. It is defined as an adenocarcinoma in which the enteric component exceeds 50% and have to show the expression of at least 1 immunohistochemical marker of enteric differentiation. Although the definition of this tumor type is very important, above all in the differential diagnosis between a primary lung tumor and a metastasis of colorectal adenocarcinoma, this cancer still lacks a distinctive immunohistochemical and molecular signature. We recruited the largest series in the literature of PAEDs according to the morphology and the positivity for intestinal markers. Then, we evaluated the immunohistochemical and molecular profile of these adenocarcinomas. In our series, CDX-2 and CK7 were the immunohistochemical markers mostly expressed by PAEDs. There was an inverse relationship between the expression of pnuemocytes markers, such as TTF-1, and intestinal markers. Molecular analysis revealed KRAS as the most frequently mutated gene (>60% of cases), with very few cases harboring abnormalities affecting EGFR, BRAF, and ALK genes. PAEDs are morphologically very heterogenous. The immunohistochemical profile based on CDX-2 and CK7 positivity of PAEDs appears very robust to support this diagnosis, and it is applicable also on small biopsies. KRAS appears as the most important mutated gene in such tumors.

U2 - 10.1097/PAI.0000000000000440

DO - 10.1097/PAI.0000000000000440

M3 - Article

VL - 26

SP - 383

EP - 387

JO - Applied Immunohistochemistry and Molecular Morphology

JF - Applied Immunohistochemistry and Molecular Morphology

SN - 1541-2016

IS - 6

ER -